Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4877-4881

  Brix, Johanna Maria ^a   Stingl, Harald ^a   Höllerl, Florian ^a   Schernthaner, Gerit Holger ^b   Kopp, Hans Peter ^a   Schernthaner, Guntram ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FETUIN A; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 78049514118     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0148     Document Type: Article

References (20)

1. Hossain P, Kawar B, El NahasM2007 Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 356:213-215
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977 (Pubitemid 13080473)
3. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC 2007 Long-term mortality after gastric bypass surgery. N Engl J Med 357:753-761
4. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM 2007 Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752
5. Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A 1989 Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58:631-640
6. Mathews ST, Rakhade S, Zhou X, Parker GC, Coscina DV, Grunberger G 2006 Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Commun 350:437-443
7. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y 2006 Association of serum fetuin- A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29:468
8. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA 2006 Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113:1760-1767 (Pubitemid 43958469)
9. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU 2006 α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853-857
10. Ix JH, Wassel CL, Chertow GM, Koster A, Johnson KC, Tylavsky FA, Cauley JA, Cummings SR, Harris TB, Shlipak MG 2009 Fetuin-A and change in body composition in older persons. J Clin Endocrinol Metab 94:4492-4498
11. Reinehr T, Roth CL 2008 Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93:4479-4485 (Pubitemid 352789550)
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
13. Rothman K, Greenland S 1998 Modern epidemiology. Philadelphia: Lippincott, Williams, Wilkins
14. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A 2008 Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555-2562
15. Rittig K, Thamer C, Haupt A, Machann J, Peter A, Balletshofer B, Fritsche A, Haring HU, Stefan N 2009 High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis 207:341-342
16. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Casuccio A, Bivona G, Bellia C, Barreca L, Serio A, D'Aguanno G, Ciaccio M, Licata G, Pinto A 2010 Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis 208:290-296
17. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG 2008 Fetuin-A and incident diabetes mellitus in older persons. JAMA 300:182-188
18. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248.e5-256.e5
19. Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G 2003 Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23:1042-1047
20. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB 2008 Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762-2767